Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 21 studies | 89% ± 16% | |
lung | 19 studies | 77% ± 20% | |
brain | 15 studies | 42% ± 21% | |
intestine | 13 studies | 76% ± 24% | |
eye | 11 studies | 56% ± 25% | |
kidney | 9 studies | 78% ± 20% | |
liver | 8 studies | 62% ± 25% | |
bone marrow | 6 studies | 81% ± 13% | |
lymph node | 6 studies | 94% ± 3% | |
uterus | 5 studies | 90% ± 11% | |
pancreas | 4 studies | 81% ± 18% | |
placenta | 4 studies | 85% ± 24% | |
adipose | 4 studies | 47% ± 28% | |
esophagus | 4 studies | 66% ± 31% | |
prostate | 4 studies | 86% ± 22% | |
breast | 4 studies | 94% ± 4% | |
heart | 3 studies | 44% ± 16% | |
adrenal gland | 3 studies | 80% ± 16% | |
skin | 3 studies | 76% ± 21% | |
thymus | 3 studies | 84% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 32841.18 | 258 / 258 | 100% | 112.20 | 230 / 230 |
bladder | 100% | 39666.95 | 21 / 21 | 100% | 124.83 | 504 / 504 |
breast | 100% | 44314.78 | 459 / 459 | 100% | 141.05 | 1118 / 1118 |
esophagus | 100% | 37629.92 | 1445 / 1445 | 100% | 89.86 | 183 / 183 |
intestine | 100% | 36469.17 | 966 / 966 | 100% | 128.77 | 527 / 527 |
ovary | 100% | 70768.13 | 180 / 180 | 100% | 102.02 | 430 / 430 |
pancreas | 100% | 25019.78 | 328 / 328 | 100% | 107.57 | 178 / 178 |
prostate | 100% | 38353.57 | 245 / 245 | 100% | 178.89 | 502 / 502 |
skin | 100% | 47537.78 | 1809 / 1809 | 100% | 117.66 | 472 / 472 |
stomach | 100% | 26760.18 | 359 / 359 | 100% | 108.08 | 286 / 286 |
thymus | 100% | 32348.41 | 653 / 653 | 100% | 157.85 | 605 / 605 |
uterus | 100% | 44769.49 | 170 / 170 | 100% | 145.95 | 459 / 459 |
kidney | 100% | 29341.47 | 89 / 89 | 100% | 111.09 | 900 / 901 |
lung | 100% | 28046.70 | 576 / 578 | 100% | 106.23 | 1155 / 1155 |
brain | 99% | 21383.92 | 2628 / 2642 | 100% | 99.37 | 705 / 705 |
liver | 99% | 14787.12 | 223 / 226 | 100% | 90.80 | 406 / 406 |
adipose | 100% | 42096.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 189.11 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 198.49 | 29 / 29 |
muscle | 100% | 71499.15 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 28959.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 124.37 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 82.08 | 1 / 1 |
blood vessel | 100% | 36181.70 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 30353.93 | 915 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 34100.16 | 834 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048742 | Biological process | regulation of skeletal muscle fiber development |
GO_0061384 | Biological process | heart trabecula morphogenesis |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006412 | Biological process | translation |
GO_0043403 | Biological process | skeletal muscle tissue regeneration |
GO_0006612 | Biological process | protein targeting to membrane |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_1905551 | Biological process | negative regulation of protein localization to endoplasmic reticulum |
GO_0042060 | Biological process | wound healing |
GO_0003231 | Biological process | cardiac ventricle development |
GO_0048633 | Biological process | positive regulation of skeletal muscle tissue growth |
GO_2000138 | Biological process | positive regulation of cell proliferation involved in heart morphogenesis |
GO_0015031 | Biological process | protein transport |
GO_0010664 | Biological process | negative regulation of striated muscle cell apoptotic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0005854 | Cellular component | nascent polypeptide-associated complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NACA |
Protein name | Nascent polypeptide-associated complex subunit alpha (NAC-alpha) (Alpha-NAC) (allergen Hom s 2) Nascent polypeptide associated complex subunit alpha Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form) (skNAC) |
Synonyms | HSD48 |
Description | FUNCTION: Prevents inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum (ER). Binds to nascent polypeptide chains as they emerge from the ribosome and blocks their interaction with the signal recognition particle (SRP), which normally targets nascent secretory peptides to the ER. Also reduces the inherent affinity of ribosomes for protein translocation sites in the ER membrane (M sites). May act as a specific coactivator for JUN, binding to DNA and stabilizing the interaction of JUN homodimers with target gene promoters. . FUNCTION: Cardiac- and muscle-specific transcription factor. May act to regulate the expression of genes involved in the development of myotubes. Plays a critical role in ventricular cardiomyocyte expansion and regulates postnatal skeletal muscle growth and regeneration. Involved in the organized assembly of thick and thin filaments of myofibril sarcomeres (By similarity). . |
Accessions | ENST00000546392.6 [Q13765-1] ENST00000678047.1 A0A7I2V2K5 ENST00000678376.1 ENST00000552540.5 [Q13765-1] ENST00000393891.8 [Q13765-1] ENST00000678066.1 [Q13765-1] ENST00000552055.5 ENST00000550952.6 [E9PAV3-2] F8W0C7 H0YHX9 ENST00000549259.5 F8VNW4 ENST00000679092.1 F8VZ58 ENST00000549855.5 ENST00000678416.1 F8W0W4 ENST00000548563.5 Q13765 ENST00000550920.6 ENST00000356769.7 [Q13765-1] ENST00000548084.1 ENST00000454682.6 [E9PAV3-1] F8VZJ2 F8W029 ENST00000547914.5 E9PAV3 ENST00000546862.6 A0A7I2V473 |